Clifford Chance has advised Symrise AG on a capital increase from its authorised capital.  Symrise issued 11,150,000 new shares to institutional investors at EUR 36 each, total around EUR 400 million. The new shares were approved for trading in the Prime Standard segment of the Regulated Market at Frankfurt Stock Exchange.

Part of the proceeds from the capital increase is due to be used to finance the acquisition of the Diana Group announced on 12 April 2014.

Symrise is a global provider of fragrances and flavours, raw materials and active ingredients for cosmetics, as well as functional ingredients. The company's turnover in FY 2013 was EUR 1.8 billion.

The Clifford Chance team comprised partner Sebastian Maerker and associate Sven Kurzawe (both Banking & Capital Markets, Frankfurt) and partner Dr. Thomas Stohlmeier, counsel Dr. Christian Vogel and associate Dr. Philipp Heer (all Corporate, Düsseldorf).

Clifford Chance recently advised Symrise on its binding purchase offer for the Diana Group and the associated bridging loan and successfully represented Symrise AG in interim injunction proceedings at Munich Regional Court brought by Ritter Sport against Stiftung Warentest.